Vulpes 750k Trade15 Dec 2020 15:55
""Scancell Holdings plc (AIM: SCLP), the developer of novel immunotherapies for the treatment of cancer and infectious disease, announces that Vulpes Life Sciences Fund ("Vulpes"), a person closely associated with Martin Diggle, Non-Executive Director, has purchased 750,000 ordinary shares of 0.1 pence each in Scancell Holdings plc ("Ordinary Shares") at a price of 10.5 pence per Ordinary Share.""
And indeed we do get an RNS this afternoon on that 750k BUY, it was Vulpes again, totalling 1m shares this week.
Indeed, we are looking stronger!!!